Ulipristal acetate: new oral treatment for uterine fibroids

Abstract Ulipristal acetate is the first progesterone receptor modulator licensed for the preoperative treatment of uterine fibroids. Our New products review presents the clinical data relating to its efficacy and adverse events and considers its place in medical management of uterine fibroids.